Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CYSB2100036	人干扰素α2a栓	recombinant human interferon α2a	Suppository	Biological Products	Supplementary Application	2021-01-19	长春生物制品研究所有限责任公司	Changchun Lnstitute of Biological Products Co Ltd	In Review	2022-01-19	view
CYSB1000703	重组人干扰素α2а栓	recombinant human interferon α2a	Suppository	Biological Products	Supplementary Application	2011-05-09	武汉维奥制药有限公司	Wuhan Wei'ao Pharmaceutical Co Ltd	Certificate Issued	2016-04-18	view
Y0410850	重组人干扰素α2a栓剂	recombinant human interferon α2a	Suppository	Biological Products	Supplementary Application	2004-09-24	武汉维奥制药有限公司	Wuhan Wei'ao Pharmaceutical Co Ltd	Certificate Issued	2004-12-31	view
CSS20020017	重组人干扰素α2a栓	recombinant human interferon α2a	Suppository	Biological Products(5)	New Drug Application	2002-04-17	武汉天奥制药有限公司		Approval Completed-Pending Certificated	2003-03-31	view
CSB01008	重组人干扰素α2a栓	recombinant human interferon α2a	Suppository	Biological Products(2)	Supplementary Application	2001-02-27		Changchun Lnstitute of Biological Products Co Ltd	Certificate Issued	2009-11-11	view